How stem cell therapy may help women with premature ovarian failure, thin endometrium, and fertility challenges. Clinical evidence for MSC-based fertility restoration.
MSC therapy targets three major causes of female infertility: (1) Diminished ovarian reserve (DOR) — MSCs injected into ovarian tissue secrete anti-apoptotic factors (IGF-1, HGF, VEGF) that protect surviving follicles, promote angiogenesis, and may reduce the accelerated follicular atresia characterising DOR and premature ovarian insufficiency (POI); (2) Asherman's syndrome / thin endometrium — MSCs promote endometrial regeneration and angiogenesis, thickening the endometrial lining to support implantation; (3) Autoimmune infertility — MSC immune modulation reduces anti-ovarian antibodies and cytokine-mediated follicular damage.
Published case series (Mohamed et al. 2018, Gabr et al. 2016) report endometrial thickness improvements from 4–5mm to 8–10mm in Asherman's cases after MSC treatment, with subsequent successful pregnancies documented. POI series report FSH normalisation and spontaneous menstruation resumption in 30–50% of patients. Fertility specialists typically recommend MSC therapy as an adjunct to IVF in poor responders — improving follicular recruitment and endometrial receptivity before the embryo transfer cycle.
StemCell Longevita's female fertility programme involves ovarian injection and/or hysteroscopy-guided endometrial MSC infusion, combined with systemic IV treatment. Pre-treatment evaluation includes AMH, AFC, FSH/LH, and uterine cavity assessment. The programme is designed to be completed in 5–7 days and coordinated with the patient's reproductive endocrinologist to integrate MSC treatment into an upcoming IVF cycle if planned.
Related articles: Stem Cell Therapy for Male Infertility: Research & Options | Understanding Stem Cell Therapy (2026 Complete Guide) | Is Stem Cell Therapy Safe? Understanding Risks, Benefits & Evidence | Mesenchymal Stem Cells (MSCs): What Every Patient Should Know
Related treatments: Anti-Aging Stem Cell Therapy | Autoimmune Disease Stem Cell Therapy | Diabetes Stem Cell Therapy